437 related articles for article (PubMed ID: 19258557)
1. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.
Crowther MA; Ageno W; Garcia D; Wang L; Witt DM; Clark NP; Blostein MD; Kahn SR; Vesely SK; Schulman S; Kovacs MJ; Rodger MA; Wells P; Anderson D; Ginsberg J; Selby R; Siragusa S; Silingardi M; Dowd MB; Kearon C
Ann Intern Med; 2009 Mar; 150(5):293-300. PubMed ID: 19258557
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases.
Denas G; Marzot F; Offelli P; Stendardo A; Cucchini U; Russo R; Nante G; Iliceto S; Pengo V
J Thromb Thrombolysis; 2009 Apr; 27(3):340-7. PubMed ID: 18338109
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: a randomised clinical trial.
Kampouraki E; Avery PJ; Wynne H; Biss T; Hanley J; Talks K; Kamali F
Br J Haematol; 2017 Sep; 178(5):800-809. PubMed ID: 28771671
[TBL] [Abstract][Full Text] [Related]
4. Vitamin K for improved anticoagulation control in patients receiving warfarin.
Mahtani KR; Heneghan CJ; Nunan D; Roberts NW
Cochrane Database Syst Rev; 2014 May; (5):CD009917. PubMed ID: 24832594
[TBL] [Abstract][Full Text] [Related]
5. Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation.
Patel RJ; Witt DM; Saseen JJ; Tillman DJ; Wilkinson DS
Pharmacotherapy; 2000 Oct; 20(10):1159-66. PubMed ID: 11034038
[TBL] [Abstract][Full Text] [Related]
6. Summaries for patients. Is vitamin K helpful for people who have taken too much warfarin?
Ann Intern Med; 2009 Mar; 150(5):I25. PubMed ID: 19258552
[No Abstract] [Full Text] [Related]
7. Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial.
Crowther MA; Douketis JD; Schnurr T; Steidl L; Mera V; Ultori C; Venco A; Ageno W
Ann Intern Med; 2002 Aug; 137(4):251-4. PubMed ID: 12186515
[TBL] [Abstract][Full Text] [Related]
8. The use of vitamin K in patients on anticoagulant therapy: a practical guide.
Hanslik T; Prinseau J
Am J Cardiovasc Drugs; 2004; 4(1):43-55. PubMed ID: 14967065
[TBL] [Abstract][Full Text] [Related]
9. Randomized, placebo-controlled trial of orally administered vitamin K1 for warfarin-associated coagulopathy in Chinese patients with mechanical heart valves.
Zhang H; Li M; Ao XL; Dong YJ; Dong L
Eur J Clin Pharmacol; 2021 Sep; 77(9):1333-1339. PubMed ID: 33783553
[TBL] [Abstract][Full Text] [Related]
10. Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial.
Schulman S; Parpia S; Stewart C; Rudd-Scott L; Julian JA; Levine M
Ann Intern Med; 2011 Nov; 155(10):653-9, W201-3. PubMed ID: 22084331
[TBL] [Abstract][Full Text] [Related]
11. Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.
Crowther MA; Julian J; McCarty D; Douketis J; Kovacs M; Biagoni L; Schnurr T; McGinnis J; Gent M; Hirsh J; Ginsberg J
Lancet; 2000 Nov; 356(9241):1551-3. PubMed ID: 11075768
[TBL] [Abstract][Full Text] [Related]
12. Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.
Tsu LV; Dienes JE; Dager WE
Ann Pharmacother; 2012 Dec; 46(12):1617-26. PubMed ID: 23249867
[TBL] [Abstract][Full Text] [Related]
13. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10.
Gunther KE; Conway G; Leibach L; Crowther MA
Thromb Res; 2004; 113(3-4):205-9. PubMed ID: 15140584
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
[TBL] [Abstract][Full Text] [Related]
15. [Oral administration of intravenous preparation of Vitamin K for excessive anticoagulation due to warfarin].
Lozada Y; Falcone M; Granero R
Medicina (B Aires); 2012; 72(2):115-8. PubMed ID: 22522851
[TBL] [Abstract][Full Text] [Related]
16. Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin.
Crowther MA; Donovan D; Harrison L; McGinnis J; Ginsberg J
Thromb Haemost; 1998 Jun; 79(6):1116-8. PubMed ID: 9657434
[TBL] [Abstract][Full Text] [Related]
17. The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin. A randomised trial.
Boonyawat K; Wang L; Lazo-Langner A; Kovacs MJ; Yeo E; Schnurr T; Schulman S; Crowther MA
Thromb Haemost; 2016 Aug; 116(3):480-5. PubMed ID: 27346552
[TBL] [Abstract][Full Text] [Related]
18. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ
Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309
[TBL] [Abstract][Full Text] [Related]
19. Management of coumarin-associated coagulopathy in the non-bleeding patient: a systematic review.
Dentali F; Ageno W
Haematologica; 2004 Jul; 89(7):857-62. PubMed ID: 15257939
[TBL] [Abstract][Full Text] [Related]
20. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
